Brian S Henick

23PUBLICATIONS
225CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Central nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Comparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 19, 2026
Screening of anti-metastasis drugs by targeting angiopellosis and cancer cluster extravasation.

|Jun 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors.

|May 18, 2026
Aneuploidy sensitizes cells to SREBP-pathway inhibition in squamous cell carcinoma.

|Mar 21, 2025
Osteoarthritis increases the risk of inflammatory arthritis due to immune checkpoint inhibitors associated with tissue-resident memory T cells.

Matthieu Paiola, Daniel M Portnoy, Luke Yi Hao

|Feb 27, 2025
Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases.

Somnath Tagore, Lindsay Caprio, Amit Dipak Amin

|Jan 27, 2025
Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.

Breelyn A Wilky, Gary K Schwartz, Michael S Gordon

Pageof 4

Frequent Collaborators

4 joint publications

Alison M Taylor

4 joint publications

Catherine A Shu

4 joint publications

Anjali Saqi

3 joint publications

Benjamin Izar